Labenz C, Arslanow A, Lammert F, Galle PR, et al. Reply to: "an individualized cirrhosis screening strategy might be more cost-effective in the general population". J Hepatol 2022 Aug 18. pii: S0168-8278(22)03006.
PMID: 35988687